This fellowship will allow the applicant to continue his studies into understanding and intervening in osteoarthritis. He will use a combination of observational studies and clinical trials to achieve this purpose.
Developing Innovative Pathways For The Prevention Of Lifelong Cardiovascular Risk
Funder
National Health and Medical Research Council
Funding Amount
$753,300.00
Summary
My research aims to develop better ways to predict the risk of heart disease, better approaches to disease prevention and treatment and to ultimately develop more effective approaches to implementing these strategies into health care delivery.
Improving Patient Management Pathways In Age-Related Macular Degeneration
Funder
National Health and Medical Research Council
Funding Amount
$181,065.00
Summary
Age related macular degeneration (AMD) is the most common cause of vision impairment in Australians aged over 50 years. In recent years, there have been a number of diagnostic tests and new interventions developed for AMD, but it has proven challenging to communicate this information to all primary eye care practitioners. This project will investigate the reasons management guidelines are not always being followed, and develop online training to provide direct bench-to-bedside AMD education.
STOP-AUST: The Spot Sign And Tranexamic Acid On Preventing Intracerebral Haemorrhage Growth – AUStralasia Trial
Funder
National Health and Medical Research Council
Funding Amount
$764,621.00
Summary
The STOP-AUST study is a randomized controlled trial with the aim of testing whether the medication tranexamic acid when given early within 4.5 hours of symptom onset is superior to standard care alone in stopping intracerebral haemorrhage (ICH, a bleeding into the brain) growth. Total 100 to 150 patients will be enrolled into the study.
Finding Clinical Predictors For The Underlying Pathology In Different Frontotemporal Dementia (FTD) Syndromes
Funder
National Health and Medical Research Council
Funding Amount
$136,593.00
Summary
Due to the ageing population in Australia it is predicted that the prevalence of dementia will increase four-fold by 2050. Developing disease-modifying therapies for dementia is therefore a priority, however we also need to be able to accurately identify patients for whom these therapies will be beneficial. Here we will develop strategies for identifying patients with particular protein abnormalities in their brain, the substrate of most therapeutic interventions.
ASPREE- NEURO; Aspirin And Cerebral Microhaemorrhages
Funder
National Health and Medical Research Council
Funding Amount
$989,195.00
Summary
Cerebral Microhaemorrhages (CMH) are tiny areas of blood vessel breakdown commonly found on brain MRIs in the elderly. Their clinical significance is not clear- prior studies have linked them to use of blood thinning medications, cognitive decline and risk of stroke. This randomised controlled trial will determine whether low dose aspirin increases the number of CMH on brain MRI in the healthy elderly after 1 and 3 years, and whether the number and location of CMH affects cognitive function.
Discovery To Therapy Implementation In Acute Stroke
Funder
National Health and Medical Research Council
Funding Amount
$585,269.00
Summary
Advances in acute stroke therapies are occurring rapidly but challenges remain in their safe and effective delivery to stroke sufferers. This research focuses on testing a potentially superior ‘clot busting’ drug therapy for acute stroke and on identifying reasons why one of the most widely used current therapies carries a risk of significant harm due to bleeding into the brain. The work also investigates how to better implement the newest form of acute therapy, mechanical blood clot extraction.
Examining New Treatments And Developing New Treatment Biomarkers For Youth With Severe Depression
Funder
National Health and Medical Research Council
Funding Amount
$338,381.00
Summary
Antidepressant medications and psychotherapy have been the mainstays of depression treatment in young people, but given their modest effectiveness, there is a pressing need for new treatment strategies. During this fellowship I aim to examine better treatments for depression, and develop better predictors about who is likely to benefit from them.
Diagnostic And Prognostic Evaluation Of Diffusion Tensor Imaging And Cognitive Function After Traumatic Brain Injury
Funder
National Health and Medical Research Council
Funding Amount
$874,404.00
Summary
Traumatic brain injuries (TBIs) are a common cause of brain damage, leading to a variety of disabling cognitive problems. This study will evaluate the ability of new brain imaging techniques and cognitive tests to detect previously undiagnosed brain damage and to predict patient outcome following TBI in order to improve the health care and treatment of these patients. It will also examine the contribution of other factors (eg. injury type, age, pre-injury cognitive ability) to outcome.